Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-21-028596
Filing Date
2021-11-15
Accepted
2021-11-15 16:10:53
Documents
69
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 1021430
2 ex31-1.htm EX-31.1 15524
3 ex31-2.htm EX-31.2 15908
4 ex32-1.htm EX-32.1 6584
5 ex32-2.htm EX-32.1 6470
  Complete submission text file 0001493152-21-028596.txt   5756881

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE vvos-20210930.xsd EX-101.SCH 44497
7 XBRL CALCULATION FILE vvos-20210930_cal.xml EX-101.CAL 64120
8 XBRL DEFINITION FILE vvos-20210930_def.xml EX-101.DEF 177607
9 XBRL LABEL FILE vvos-20210930_lab.xml EX-101.LAB 383026
10 XBRL PRESENTATION FILE vvos-20210930_pre.xml EX-101.PRE 303427
11 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 899905
Mailing Address 9137 RIDGELINE BOULEVARD SUITE 135 HIGHLANDS RANCH CO 80129
Business Address 9137 RIDGELINE BOULEVARD SUITE 135 HIGHLANDS RANCH CO 80129 (866)908-4867
Vivos Therapeutics, Inc. (Filer) CIK: 0001716166 (see all company filings)

EIN.: 813224056 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39796 | Film No.: 211410615
SIC: 3841 Surgical & Medical Instruments & Apparatus